PainChek Limited (PCK.AX)
AUD 0.03
(-7.14%)
AUD 0.03
(-7.14%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -9.48 Million AUD | -10.25% |
| 2023 | -8.6 Million AUD | -15.45% |
| 2022 | -6.79 Million AUD | 14.98% |
| 2021 | -8.9 Million AUD | 40.59% |
| 2020 | -13.14 Million AUD | -360.15% |
| 2019 | -4 Million AUD | 32.19% |
| 2018 | -4.8 Million AUD | -20.01% |
| 2017 | -3.89 Million AUD | -209.62% |
| 2016 | -57.38 Thousand AUD | -38.49% |
| 2015 | -927 Thousand AUD | -19.7% |
| 2014 | -766.21 Thousand AUD | 32.46% |
| 2013 | -1.07 Million AUD | -172.33% |
| 2012 | -404.93 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -3.29 Million AUD | 0.0% |
| 2024 FY | - AUD | -8.58% |
| 2024 Q4 | -4.99 Million AUD | 0.0% |
| 2023 FY | - AUD | -15.45% |
| 2023 Q2 | -3.09 Million AUD | 0.0% |
| 2023 Q4 | -4.46 Million AUD | 0.0% |
| 2022 Q2 | -1.79 Million AUD | 0.0% |
| 2022 Q4 | -3.92 Million AUD | 0.0% |
| 2022 FY | - AUD | 14.98% |
| 2021 Q4 | -4.75 Million AUD | 0.0% |
| 2021 Q2 | -3.37 Million AUD | 0.0% |
| 2021 FY | - AUD | 40.59% |
| 2020 Q2 | -9.83 Million AUD | 0.0% |
| 2020 Q4 | -2.56 Million AUD | 0.0% |
| 2020 FY | - AUD | -360.15% |
| 2019 Q2 | -1.21 Million AUD | 0.0% |
| 2019 Q4 | -2.04 Million AUD | 0.0% |
| 2019 FY | - AUD | 32.19% |
| 2018 Q4 | -1.38 Million AUD | 0.0% |
| 2018 FY | - AUD | -20.01% |
| 2018 Q2 | -3.41 Million AUD | 0.0% |
| 2017 FY | - AUD | -209.62% |
| 2017 Q4 | -3.89 Million AUD | -84.06% |
| 2017 Q3 | -2.11 Million AUD | 53.69% |
| 2017 Q2 | -4.57 Million AUD | 0.0% |
| 2016 Q2 | -1.16 Million AUD | -181.32% |
| 2016 FY | - AUD | -38.49% |
| 2016 Q1 | -414.13 Thousand AUD | 0.0% |
| 2016 Q4 | -1.16 Million AUD | 0.0% |
| 2016 Q3 | -1.16 Million AUD | 0.0% |
| 2015 Q4 | -414.13 Thousand AUD | 0.0% |
| 2015 Q3 | -414.13 Thousand AUD | 0.0% |
| 2015 Q2 | -414.13 Thousand AUD | -116.2% |
| 2015 Q1 | -191.55 Thousand AUD | 0.0% |
| 2015 FY | - AUD | -19.7% |
| 2014 Q2 | -191.55 Thousand AUD | 28.65% |
| 2014 Q1 | -268.45 Thousand AUD | 0.0% |
| 2014 FY | - AUD | 32.46% |
| 2014 Q4 | -191.55 Thousand AUD | 0.0% |
| 2014 Q3 | -191.55 Thousand AUD | 0.0% |
| 2013 Q4 | -268.45 Thousand AUD | 0.0% |
| 2013 Q3 | -268.45 Thousand AUD | 0.0% |
| 2013 Q2 | -268.45 Thousand AUD | -165.18% |
| 2013 Q1 | -101.23 Thousand AUD | 0.0% |
| 2013 FY | - AUD | -172.33% |
| 2012 Q3 | -101.23 Thousand AUD | 0.0% |
| 2012 Q2 | -101.23 Thousand AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | -101.23 Thousand AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alcidion Group Limited | -4.49 Million AUD | -111.043% |
| Artrya Limited | -13.95 Million AUD | 32.006% |
| Beamtree Holdings Limited | -331 Thousand AUD | -2766.616% |
| Cogstate Limited | 9.89 Million AUD | 195.928% |
| Careteq Limited | -826.61 Thousand AUD | -1047.873% |
| Doctor Care Anywhere Group PLC | -8.35 Million AUD | -13.58% |
| Emyria Limited | -13.03 Million AUD | 27.207% |
| Global Health Limited | -1.76 Million AUD | -437.356% |
| HITIQ Limited | -2.54 Million AUD | -273.178% |
| Intelicare Holdings Limited | -3.02 Million AUD | -214.135% |
| ImExHS Limited | -1.25 Million AUD | -654.42% |
| Mach7 Technologies Limited | -2.44 Million AUD | -288.548% |
| MedAdvisor Limited | 7.04 Million AUD | 234.621% |
| Oakridge International Limited | -630.05 Thousand AUD | -1405.984% |
| Opyl Limited | -3.2 Million AUD | -195.661% |
| Pro Medicus Limited | 120.76 Million AUD | 107.857% |
| Resonance Health Limited | -457 Thousand AUD | -1976.222% |
| Singular Health Group Ltd | -2.88 Million AUD | -228.875% |
| Total Brain Limited | -5.49 Million AUD | -72.797% |